Skip to main content
SpringerLink
Log in

Pharmacology of Different Administration Routes - Oral vs Transdermal

  • Chapter
Estrogens and Antiestrogens II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 135 / 2))

Abstract

For a drug to produce its effect, it must be present in an appropriate concentration at the site of action. This concentration will be influenced by the dose, the rate and the amount of absorption, how the drug is distributed in the body, how it is metabolized and how rapidly it is excreted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alkjaersig N, Fletcher AP, De Ziegler D, Steingold KA, Meldrum DR, JuddHL(1988)Blood coagulation in postmenopausal women given estrogen treatment. Comparison of transdermal and oral administration. J Lab Clin Med 111:224–228

    CAS  Google Scholar 

  • Baker V (1994) Alternatives to oral estrogen replacement. Obstet Gynecol Clin North Amer 21(2)271–297

    CAS  Google Scholar 

  • Baracat E, Tufik S, Castelo A, Rodrigues de Lima G, Haidar M, Casoy J, Peloso U (1995)Comparative bioavailability of a matrix versus a reservoir transdermal estradiol patch in healthy postmenopausal women. Curr Ther Res 56(4)358–368

    Article  CAS  Google Scholar 

  • Barnes RD, Lobo RA (1987)Pharmacology of estrogens. In: Mishell DR Jr (ed)Menopause. Physiology and Pharmacology. Chicago, Year Book Medical Publishers, pp 301–315

    Google Scholar 

  • Borg ML, Gimona A, Renoux A, Douin MJ, Djebbar F, Panis-Rouzier R (1995). Pharmacokinetics of estradiol and estrone following repeated administration of Menorest, a new estrogen transdermal delivery system, in menopausal women. Clin Drug Invest 10(2)96–103

    Article  CAS  Google Scholar 

  • Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM et al(1987)Cardiovascular mortality and non contraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation: 75:1102–1109

    Article  PubMed  CAS  Google Scholar 

  • Buster JE (1985) Estrogen metabolism. In: Sciarra JJ (ed)Gynecology and Obstetrics. Philadelphia, Harper and Row

    Google Scholar 

  • Cagnacci A, Soldani R, Carriero PL, Pauletti AM, Fioretti P, Melis GB (1992)Effects of low doses of transdermal 17 j3-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396–1400

    Article  PubMed  CAS  Google Scholar 

  • Cheang A, Sitruk-Ware R, Utian W(1993)A risk-benefit appraisal of transdermal estradiol therapy. Drug Safety 9(5)365–379

    Article  PubMed  CAS  Google Scholar 

  • Cheang A, Sitruk-Ware R, Samsioe G(1994)Transdermal oestradiol and cardiovascular risk factors. 101:571–581

    Google Scholar 

  • Chetkowski RJ, Meldrum DR, Steingold KA, Randle R, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL(1986)Biologic effects of transdermal estradiol. N Engl J Med 314:1615–1620

    Google Scholar 

  • Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol I(1980)Prevention of early postmenopausal bone loss: a controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273–279

    Article  PubMed  CAS  Google Scholar 

  • Clarck JH, Peck EJ Jr(1979)Female Sex Steroids. Receptors and Function. Monographs on Endocrinology. New York, SpringerClisham P, Cedars MI, Greendale G, Fu YS, Gambone J, Judd H (1992) Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.Obstet Gynecol 79:196–201

    Google Scholar 

  • Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH (1987)Menopause and the risk of coronary heart disease in women. N EngI J Med 316:1105–1110

    Article  CAS  Google Scholar 

  • Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA(1993)Cardiovascular protection by estrogen, a calcium antagonist effect. 341:1264–1265

    Google Scholar 

  • Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, Stevenson JC, Whitehead MI, Wynn V(1992)Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 166:950–955

    Google Scholar 

  • De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyenne TT, Mairon N, Corvol P, Guy-Grand B, Mauvais-Jarvis P, Sitruk-Ware R(1986)Biological effects of estradiol 17 f3 in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 62:536–541

    Article  PubMed  Google Scholar 

  • Erkkola RU, Hirvonen EJ, Juntunen K, Saastamoinen JA, Tuimala RJ, Rinne R, Paakkari I(1995)Comparison of transdermal to oral hormone replacement therapy. Eur Menopause J 2:21–27

    Google Scholar 

  • Ettinger B, Genant HK, Steiger P, Madvig P(1992)Low dosage micronised 17 f3 estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 166:479–488

    PubMed  CAS  Google Scholar 

  • Field CS, Ory SJ, Wahner HW, Hermann RR, Judd HL, Riggs BL(1992)Preventive effects of trans dermal 17 f3-estradiol on osteoporotic changes after surgical menopause: a two year placebo-controlled trial. Am J Obstet Gynecol 168:114–121

    Google Scholar 

  • Foidart JM, Dombrowicz N, De Lignieres B (1991) Urinary excretion of prostacylin and thromboxane metabolites in postmenopausal women treated with percutaneous estradiol (Oestrogel) or conjugated estrogens (Premarin): In: Dusitsin N et al. (eds)Physiological hormone replacement therapy. Carnforth Parthenon, pp 99–107

    Google Scholar 

  • Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC(1993)Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846–853

    Article  PubMed  CAS  Google Scholar 

  • Goebelsmann U, Mashchak A, Mishell DR Jr(1985)Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 151:868–877

    PubMed  CAS  Google Scholar 

  • Gurpide E (1978) Metabolic influences of the action of estrogens: therapeutic implications. Pediatrics (Suppl) 62:1114–1120

    CAS  Google Scholar 

  • Hassager C, Jensen SB, Christiansen C(1994)Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist?Osteoporosis Int 4:36–41

    Article  CAS  Google Scholar 

  • Helgason S (1982)Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand (Suppl) 107:5–29

    Google Scholar 

  • Henzl MR (1986) Contraceptive hormones and their clinical use. In: Yen SSE, Jaffe RB (eds)Reproductive Endocrinology 2nd edition. Saunders, Philadelphia, pp 643–682

    Google Scholar 

  • Hillard TC, Whitcroft SJ, March MS, Ellerington MC, Lees B, Whitehead MJ, Stevenson JC (1994)Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporosis Int 4:341–348

    Article  CAS  Google Scholar 

  • Holdright DR, Sullivan AK, Wright CA, Sparrow JL, Cunningham D, Fox KM(1995)Acute effect of estrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease. Eur Heart J 16:1566–1570

    PubMed  CAS  Google Scholar 

  • Hulley S, Grady D, Bush T, Furberg C, Herrington 0, Riggs B, Vittinghoff E(1998)Heart and estrogen/progestin replacement study (HERS) research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 208:605–613

    Article  Google Scholar 

  • James 1M (1996) Pharmacological principles of drug action. In: Ginsburg J (ed)Drug therapy in Reproductive Endocrinology. London, Arnold, pp 1–20

    Google Scholar 

  • Jensen J, Christiansen C(1988)Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 159:820–825

    Google Scholar 

  • Jensen J, Riis BJ, Strom V, Nilas L, Christiansen C(1987)Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 156:66–71

    PubMed  CAS  Google Scholar 

  • Kiel DP, Baron JA, Anderson 11, Hannan MT, Felson DT (1992)Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 116:716–721

    PubMed  CAS  Google Scholar 

  • King RJB, Dyer G, Collins WP (1980)Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins. J Steroid Biochem 13:377–382

    Article  PubMed  CAS  Google Scholar 

  • Lobo RA, March CM, Goebelsmann V, Krauss RM, Mishell DR Jr (1980)Subdermal estradiol pellets following hysterectomy and oophorectomy. Am J Obstet Gynecol 138:714–719

    PubMed  CAS  Google Scholar 

  • MacIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Healy MJR (1988)Calcitonin for prevention of postmenopausal bone loss. Lancet 1:900–902

    Article  PubMed  CAS  Google Scholar 

  • Marty JP, James M, Hajo N, Wepierre J (1980)Percutaneous absorption of oestradiol and progesterone: pharmacokinetic studies. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous absorption of steroids. London, Academic Press, pp 205–218

    Google Scholar 

  • Mashchak CA, Lobo RA, Dozono-Takano R (1982)Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 144:511–518

    PubMed  CAS  Google Scholar 

  • Mishell DR Jr, Moore DE, Roy S, Brenner PF, Page MA (1978)Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel. Am J Obstet Gynecol 130:55–62

    PubMed  CAS  Google Scholar 

  • Pang SC, Greendale GA, Cedars MI, Cambone JC, Lozano K, Eggena P, Judd HL(1993)Long term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil Steril 59:76–82

    PubMed  CAS  Google Scholar 

  • Perez-Gutthann S, Garcia-Rodriguez LA, Duque-Oliart A, Castellsague- Pique J (1995)HRT and the risk of venous thromboembolic event. Pharmacoepidemiol Drug Safety 4(Suppl 1 Abstract 118):S53

    Google Scholar 

  • Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA(1985)Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 j3-estradiol: comparison with conventional oral estrogen used for hormone replacement. Am J Obstet Gynecol 152:1099–1106

    PubMed  CAS  Google Scholar 

  • Reginster JY, Sarlet N, Deroisy R,Albert A, Gaspard U, Franchimont P(1992)Minimal levels of serum estradiol prevent postmenopausal bone loss. Calcif Tissue Int 51:340–343

    Article  PubMed  CAS  Google Scholar 

  • Rigg LA, Hermann H, Yen SSC( 1978)Absorption of estrogens from vaginal creams. N Engl J Med 298:195–197

    Article  PubMed  CAS  Google Scholar 

  • Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P(1993)Beneficial effects of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 342:133–136

    Article  PubMed  CAS  Google Scholar 

  • Setnikar I, Rovati LC, Thebault 11, Guillaume M, Mignot A, Renoux A, Gualano V(1997)Pharmacokinetics of estradiol and estrone during application of three strengths of an estradiol transdermal patch with active matrix. Arzneim ForschlDrug Res 47(II)n7:859–865

    CAS  Google Scholar 

  • Sitruk-Ware R, Ibarra de Palacios P(1989)Estrogen replacement therapy and cardiovascular disease in postmenopausal women. A review. Maturitas 11:259–274

    Article  PubMed  CAS  Google Scholar 

  • Sitruk-Ware R, De Lignieres B, Basdevant A, Mauvais-Jarvis P (1980) Absorption of percutaneous oestradiol in postmenopausal women. Maturitas 2:207–211

    Article  PubMed  CAS  Google Scholar 

  • Stampfer MJ, Colditz GA(1991)Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 20:47–63

    Article  PubMed  CAS  Google Scholar 

  • Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo A(1988)A randomized comparison of non-oral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 159:1540–1546

    PubMed  CAS  Google Scholar 

  • Steingold KA, Cefalu W, Pardrige W, Judd HL, Chaudhuri G(1986) Enhanced hepatic extraction of estrogens used for replacement therapy. J Clin Endocrinol Metab 62:761–766

    Article  PubMed  CAS  Google Scholar 

  • Studd JWW, McCarthy K, Zamblera D, Burger HG, Silberberg S, Wren B, Dain MP, Le Lann L, Vandepol C(1995)Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women.A randomised, multicentre, double-blind, double-dummy study.Maturitas 22:105–114

    Article  PubMed  CAS  Google Scholar 

  • The writing group for the PEPI trial. (1995)Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Trial.JAMA 273:199–208

    Google Scholar 

  • The writing group for the PEPI Trial (1996)Effects of hormone replacement therapy on endometrial histology in postmenopausal women.JAMA 275:370–375

    Google Scholar 

  • Von Schoultz B (1988) Potency of different estrogen preparations. In: Studd JWW, Whitehead MI (eds)The Menopause. Oxford, Blackwell Scientific, pp 130–137

    Google Scholar 

  • Whitehead MI, Townsend PT, Kitchin Y (1980)Plasma steroid and protein hormone profiles in postmenopausal women following topical administration of estradiol 17/3. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds)Percutaneous Absorption of Steroids. London, Academic Press, pp 231–248

    Google Scholar 

  • Wiseman LR, McTavish D(1994)Transdermal Estradiol/Norethisterone. Drugs and Aging 4:238–256

    Article  PubMed  CAS  Google Scholar 

  • Woodruff JD, Pickar J (1994)Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxy progesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 70:1213–1223

    Google Scholar 

  • Wynn V, Adams PW, Godsland I, Melrose J, Niththyananthan R, Oakley NW, Seed M(1979)Comparison of effects of different combined oral contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1:1045–1049

    Article  PubMed  CAS  Google Scholar 

  • Yen SSC, Martin PL, Burnier AM, Czekala NM, Greney MO Jr, Callantine MR(1975)Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17 f3-estradiol in postmenopausal women. J Clin Endocrinol Metab 40:518–520

    Article  PubMed  CAS  Google Scholar 

  • Ylikorkala 0, Orpana A, Puolakka I, Pyoriila T, Viinikka L(1995) Postmenopausal hormonal replacement decreases plasma levels of endothelin I.J Clin Endocrinol Metab 80:3384–3387

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Sitruk-Ware
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sitruk-Ware, R. (1999). Pharmacology of Different Administration Routes - Oral vs Transdermal. In: Estrogens and Antiestrogens II. Handbook of Experimental Pharmacology, vol 135 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60107-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60107-1_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64261-6

  • Online ISBN: 978-3-642-60107-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation